The presentation will be webcast live and may be accessed through C4T’s website on the Events & Presentations page. A replay of the webcast will be archived on the C4T website for at least two weeks ...

Objective Both belimumab and telitacicept are recognised blockers for B lymphocyte activation, both of which have been ...